Sothema targets Angola, Ethiopia, Kenya and Tanzania for new operations
The Moroccan pharmaceutical group, headed by Lamia Tazi, expects to end 2022 with a turnover of MAD 2.3 billion (about €215 million), up 12%.
02/09/2022 at 16h36, by Africa Business+
Mohamed Tazi, director and executive director of Sothema, told Africa Business+, “The trend should improve between 2023 and 2025 thanks to our organic growth and external growth projects.”
Recommended articles
Law firm
17/03/2023 at 17h09, by Africa Business+
Legal advisers in the Angola v Aenergy case awaiting US hearing
Angola and Aenergy, an electricity company owned by the Portuguese national, Ricardo Machado, have been...
Health
27/05/2022 at 15h26, by Africa Business+
Blink Pharma looking at second round of financing
The Moroccan entity recently raised $820,000 (MAD 8.2 million) from Azur Innovation Fund – a first.
Health
25/04/2022 at 12h00, by Africa Business+
BluePeak invests in Africure Pharmaceutical and targets two other companies
The young alternative asset management firm based in London, Nairobi and Tunis is to provide mezzanine...
Health
18/01/2022 at 16h22, by Africa Business+
Frank Roger Djoko Bansi promoted to head Eurapharma’s Uniphart in Togo
The Cameroonian, who has a doctorate in pharmacy, was appointed to head the Eurapharma subsidiary in...
Health
22/01/2020 at 14h58, by Aurelie Benoit
Morocco: Omar Tazi (Sothema) retires and hands over to his daughter Lamia
The daughter of the founder of the Moroccan pharmaceutical laboratory takes over as Chairman and CEO...